CAPTRUST Financial Advisors
CCCC icon

CAPTRUST Financial Advisors’s C4 Therapeutics CCCC Stock Holding History

CAPTRUST Financial Advisors’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,889
Closed -$33.1K – 2756
2025
Q3 		$33.1K Sell
14,889
-2,150
-13% -$5.16K ﹤0.01% 2587
2025
Q2 		$24.4K Buy
17,039
+637
+4% +$926 ﹤0.01% 2466
2025
Q1 		$26.2K Buy
16,402
+2,073
+14% +$6.18K ﹤0.01% 2310
2024
Q4 		$51.6K Sell
14,329
-678
-5% -$3.37K ﹤0.01% 2235
2024
Q3 		$85.5K Buy
15,007
+185
+1% +$1.11K ﹤0.01% 2207
2024
Q2 		$68.5K Hold
14,822
– – ﹤0.01% 2133
2024
Q1 		$121K Hold
14,822
– – ﹤0.01% 2047
2023
Q4 		$83.7K Sell
14,822
-33
-0.2% -$75 ﹤0.01% 2545
2023
Q3 		$27.6K Sell
14,855
-1,875
-11% -$5.72K ﹤0.01% 2512
2023
Q2 		$46K Buy
16,730
+1,388
+9% +$4.46K ﹤0.01% 2434
2023
Q1 		$48.2K Buy
+15,342
New +$90.3K ﹤0.01% 2216
2022
Q4 		– Sell
-14,822
Closed -$130K – 2079
2022
Q3 		$130K Hold
14,822
– – ﹤0.01% 1901
2022
Q2 		$112K Hold
14,822
– – ﹤0.01% 2120
2022
Q1 		$360K Sell
14,822
-4,940
-25% -$120K ﹤0.01% 1330
2021
Q4 		$636K Sell
19,762
-6,587
-25% -$260K ﹤0.01% 1004
2021
Q3 		$1.18M Hold
26,349
– – 0.01% 690
2021
Q2 		$997K Buy
26,349
+26,241
+24,297% +$940K 0.01% 720
2021
Q1 		$4K Buy
+108
New +$4.3K ﹤0.01% 3797

Other funds holding CCCC

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

CAPTRUST Financial Advisors's CCCC Position: Q4 2025 in Review

CAPTRUST Financial Advisors sold out of C4 Therapeutics (CCCC) in Q4 2025, closing a stake of 14,889 shares — an estimated $33.1K sold.

CAPTRUST Financial Advisors first reported a position in CCCC in Q1 2021 and held it in 18 quarters. The position peaked at $1.18M in Q3 2021. 101 funds tracked by Wall St. Rank hold CCCC as of Q4 2025.

  • CAPTRUST Financial Advisors reported no remaining C4 Therapeutics position as of Q4 2025 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 14,889 C4 Therapeutics shares in Q4 2025, an estimated $33.1K.
  • CAPTRUST Financial Advisors first reported a position in C4 Therapeutics in Q1 2021 and held it in 18 quarters.
  • CAPTRUST Financial Advisors's C4 Therapeutics position peaked at $1.18M in Q3 2021.
  • 101 funds tracked by Wall St. Rank held C4 Therapeutics as of Q4 2025.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.